# EDGAR Filing Document

**Accession Number:** 0001567264
**File Stem:** 0001213900-23-008458
**Filing Date:** 2023-2
**Character Count:** 2957
**Document Hash:** ff41b4da8ce51b9fc3af236d5d8af2b4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-008458.hdr.sgml**: 20230728

**ACCESSION NUMBER**: 0001213900-23-008458

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230206

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTENSITY THERAPEUTICS, INC.
- **CENTRAL INDEX KEY:** 0001567264
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 461488089
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 61 WILTON ROAD, 3RD FLOOR
- **CITY:** WESTPORT
- **STATE:** CT
- **ZIP:** 06880
- **BUSINESS PHONE:** 203-221-7381

**MAIL ADDRESS:**
- **STREET 1:** 61 WILTON ROAD, 3RD FLOOR
- **CITY:** WESTPORT
- **STATE:** CT
- **ZIP:** 06880

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Intensity Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20130117

February 6, 2023

***VIA EDGAR***

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | Intensity Therapeutics, Inc. |
|  | Registration Statement on Form S-1 |
|  | File No. 333-260565 |
|  | Request for Acceleration of Effective Date |

---

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the "**Act**"), we, as representative of the several underwriters, hereby join in the request of Intensity Therapeutics, Inc. (the "**Company**") for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:30 PM, Eastern Time, on February 8, 2023, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, McDermott Will & Emery LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement.

We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| Acting severally on behalf of itself and the several underwriters | Acting severally on behalf of itself and the several underwriters | Acting severally on behalf of itself and the several underwriters |
| THE BENCHMARK COMPANY, LLC | THE BENCHMARK COMPANY, LLC | THE BENCHMARK COMPANY, LLC |
| By: | /s/ Michael Jacobs | /s/ Michael Jacobs |
|  | Name: | Michael Jacobs |
|  | Title: | MD/Head of ECM |

---